SLC1A5 and breast carcinoma: IL-4 is a Th2 cytokine that interacts with the IL-4 receptor (IL-4R) and has been reported as a regulator of high ASCT2 mRNA and protein expression, enhancing glutamine uptake in breast cancer cells [102].